Log In
Print
BCIQ
Print
Print this Print this
 

AmBiL

  Manage Alerts
Collapse Summary General Information
Company Taiwan Liposome Co. Ltd.
DescriptionLiposomal formulation of amphotericin B
Molecular Target
Mechanism of Action 
Therapeutic ModalityMacrocycle
Latest Stage of DevelopmentMarketed
Standard IndicationFungal infection
Indication DetailsTreat systematic fungal infection
Regulatory Designation
Partner Novartis AG; Novartis AG; Sam Chun Dang Pharmaceutical Co. Ltd.; Yung Shin Pharmaceutical Industrial Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today